CA-SYSDIG
7.3.2024 16:01:30 CET | Business Wire | Press release
Sysdig, the leader in cloud security powered by runtime insights, today announced that the company was named a Strong Performer — one of only two vendors to receive the recognition — in Gartner Peer Insights “Voice of the Customer” for Cloud Security Posture Management (CSPM) Tools. Sysdig is the only cloud security platform to receive the maximum of five stars in the report, which was derived directly from verified customer feedback, and synthesizes reviews and ratings received as of November 30, 2023.
In addition to receiving the highest overall rating, Sysdig received top marks in each category:
- Product Capabilities: 4.9/5
- Sales Experience: 4.9/5
- Deployment Experience: 4.9/5
- Support Experience: 5/5
As the cloud landscape continues to evolve, Sysdig is at the forefront of cloud security innovation, offering active cloud risk prioritization, vulnerability management, and compliance solutions that go beyond traditional static checks. The company's dedication to providing comprehensive visibility and robust security measures has garnered widespread acclaim from its user base, as it believes is evidenced by its exceptional ratings in the Gartner “Voice of the Customer” report.
"Customers demand and deserve excellence, and we are thrilled to receive such high praise in the Gartner Voice of the Customer report. We believe a 5 out of 5 rating underscores our commitment to CISOs and boards to keep their cloud environment safe," said Knox Anderson, SVP of Product Management at Sysdig. "The industry knows Sysdig as the leader in CNAPP, and now they can feel confident knowing how much our customers love our CSPM solution."
Read the full “Voice of the Customer” report for Cloud Security Posture Management Tools.
Sysdig Customers Praise Productivity Driven by Runtime Insights
The cloud is a dynamic environment where new risks and threats can appear at any time. Most CSPM solutions perform periodic scanning, which only shows static risk and leaves visibility gaps for attackers to exploit. Sysdig empowers organizations to strengthen their cloud security posture through unified findings with active risk prioritization, agentless scanning, attack path analysis, inventory, and real-time security posture checks. Using runtime insights, Sysdig offers unparalleled visibility into active cloud risk, such as real-time configuration changes, suspicious user activity, in-use permission and packages, and workload threats.
By prioritizing active cloud risk, security teams can work more productively by reducing alert fatigue and focusing on addressing the most imminent active threats in their cloud environment. In essence, Sysdig strengthens organizations’ approaches to cloud security posture management, from risk prioritization and vulnerability management to proactive threat detection and compliance, giving them peace of mind that their assets are protected when cloud attacks can happen in a matter of minutes.
Customer feedback highlighted Sysdig's unique approach to CSPM, with users praising the platform for its comprehensive cloud-native security features and ability to improve incident response times. But CSPM is only one part of the Sysdig cloud-native application protection platform (CNAPP), which combines CSPM with cloud workload protection, cloud infrastructure entitlement management, and detection and response in a single security platform to provide customers with end-to-end coverage, from prevention to defense. With Sysdig, organizations can mitigate security issues fast, bolster operational efficiency across multi-cloud environments, and protect the entire software development life cycle.
What our Customers are Saying in Gartner Peer Insights
“I’m genuinely impressed with the level of real-time security posture checks [Sysdig] brings to our cloud infrastructure. The solution has proven to be an invaluable asset in ensuring the safety of our cloud-native application and data.” [Read the full review here]
- Director of Strategic Initiatives; Software Company
“Sysdig CSPM provides unmatched insight and fortified security for cloud-native infrastructure with state-of-art technology. Powered by Falco, it offers comprehensive visibility, empowering businesses to monitor and safeguard cloud assets efficiently…” [Read the full review here]
- VP, IT Security and Risk Management; Financial Company
“Our adoption of Sysdig CSPM was fueled by the growing complexity of our cloud environment. As our presence expanded rapidly, robust security and compliance became imperative. We required a unified solution that could monitor, detect, and manage risk across both AWS and GCP.” [Read the full review here]
- Director of Strategic Initiatives; Software Company
“Since implementing Sysdig CSPM, our incident response time has drastically improved, allowing us to mitigate security issues promptly.” [Read the full review here]
- Information Security Officer; IT Services Company
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product, or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, PEER INSIGHTS is a registered trademark of Gartner, Inc. and/or its affiliates and both are used herein with permission. All rights reserved.
This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available here.
Resources
- Visit Sysdig’s page on Gartner Peer Insights.
- Read Sysdig's blog, “Customers Rate Sysdig 5 Out of 5 in Gartner ‘Voice of the Customer’ for Cloud Security Posture Management Tools” to learn more about the announcement.
- Watch “Sysdig. Secure Every Second.” to learn more about the company.
About Sysdig
In the cloud, every second counts. Attacks move at warp speed, and security teams must protect the business without slowing it down. Sysdig stops cloud attacks in real time, instantly detecting changes in risk with runtime insights and open source Falco. Sysdig correlates signals across cloud workloads, identities, and services to uncover hidden attack paths and prioritize real risk. From prevention to defense, Sysdig helps enterprises focus on what matters: innovation. Sysdig. Secure Every Second.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240307640009/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
